Friday, 22 January 2021

Thermo Fisher unveils managed equipment solutions

07 January 2021 | News

Managed Equipment Solutions (MES) is ideal for biopharma companies, academic institutions, healthcare organisations and industrial businesses

Source credit: Thermo Fisher

Source credit: Thermo Fisher

Thermo Fisher Scientific Inc has announced the launch of Managed Equipment Solutions, a new subscription-based offering that bundles instrument and equipment procurement with consumables, applications support, software, training and extended service in a convenient and cost-efficient agreement.

Managed Equipment Solutions (MES) is ideal for biopharma companies, academic institutions, healthcare organisations and industrial businesses seeking innovative procurement models that offer all the benefits of premium instrument procurement but with increased flexibility. MES gives customers in research, life sciences, specialty diagnostics and applied markets the assurance of long-term, consistent analytical technology performance with predictable subscription costs and a pathway to future innovation.

"Managed Equipment Solutions is a direct result of our customers asking for a value-added offering that gives them convenient and timely access to our latest instrumentation and equipment innovations," said Dan Shine, Senior Vice President, and President, Thermo Fisher's Analytical Instruments business. "Through a predictable, fixed-budget subscription, customers can bundle premium technology with all the associated products and services required to support their workflows now, as well as in the future as their research and application needs evolve."  

As an integrated solution, MES can reduce total cost of ownership while preserving capital budgets. Meanwhile, it protects against technology obsolescence by enabling customers to upgrade their instruments and equipment every three to five years. MES is provided through a single, easy to manage agreement, resulting in a highly streamlined procurement process.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account






Survey Box

Should we be cautious of viewing COVID-19 vaccine as silver bullet?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls